Molecular Pathology: Biomarkers, Genomic Testing, Precision Oncology and Personalized Cancer Diagnosis | Molecular Diagnostics in Personali

The pathology of Molecular Diagnostics in Personalized Cancer Medicine is explored through biomarkers, precision oncology, and mutation testing, demonstrating how ancillary testing refines diagnosis. Diagnostic context includes molecular diagnostics, genomic testing, biomarkers, specimen handling, architecture, cytologic detail, and clinicopathologic correlation specific to this topic. Long-tail searches such as precision oncology, mutation testing, and personalized cancer medicine are addressed with attention to grading, staging, biomarkers, special stains, immunohistochemistry, or molecular testing when applicable. For pathology case 89, the emphasis remains on reproducible microscopic criteria, differential diagnosis, reporting language, and how tissue findings influence treatment planning. Careful interpretation also requires correlation with